Highlight topics

  • Current and future management of CHB
  • Liver transplant for HCV
  • NASH in Asia-Pacific: what’s new?
  • Pharmacologic management of NASH: Towards a new paradigm
  • What AASLD-IDSA guidance says
  • Guidance versus real life practice in the US
  • Hepatitis C and transplantation: is it time to change our thinking?
  • Hepatitis B Guidelines over the decades: Western perspective
  • New paradigms in the management of HBV:
    Long Term & Stopping role in the management of NUC Therapy
  • HBV-Pathobiology
  • The management of lean NASH: No weight and no time to lose?